ProfileGDS4132 / 214769_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 84% 88% 88% 80% 85% 86% 85% 90% 81% 87% 87% 87% 90% 90% 80% 88% 88% 81% 84% 90% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101303.6884
GSM201543Muscle PCOS pioglitazone 121338.91588
GSM201544Muscle PCOS pioglitazone 161407.81188
GSM201545Muscle PCOS pioglitazone 201294.63880
GSM201829Muscle PCOS pioglitazone 231340.38385
GSM201830Muscle PCOS pioglitazon 251347.59586
GSM201831Muscle PCOS pioglitazone 271332.54285
GSM201832Muscle PCOS pioglitazone 31420.95590
GSM201833Muscle PCOS pioglitazone 41277.40181
GSM201834Muscle PCOS pioglitazone 81373.41287
GSM201835Muscle PCOS after pioglitazone 102381.38687
GSM201836Muscle PCOS after pioglitazone 122374.03487
GSM201837Muscle PCOS after pioglitazone 162434.17890
GSM201838Muscle PCOS after pioglitazone 202506.87490
GSM201839Muscle PCOS after pioglitazone 232286.3480
GSM201840Muscle PCOS after pioglitazone 252409.48388
GSM201841Muscle PCOS after pioglitazone 272379.59988
GSM201842Muscle PCOS after pioglitazone 32268.31381
GSM201843Muscle PCOS after pioglitazone 42323.31784
GSM201844Muscle PCOS after pioglitazone 82479.88990